Chapter 7. Cognitive Enhancers and Treatments for Alzheimer's Disease

  1. Jeffrey A. Lieberman M.D. Professor Chair1 and
  2. Allan Tasman M.D. Professor Chair2

Published Online: 3 JUL 2006

DOI: 10.1002/0470029439.ch7

Handbook of Psychiatric Drugs

Handbook of Psychiatric Drugs

How to Cite

Lieberman, J. A. and Tasman, A. (2006) Cognitive Enhancers and Treatments for Alzheimer's Disease, in Handbook of Psychiatric Drugs, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470029439.ch7

Author Information

  1. 1

    Department of Psychiatry, Columbia University, College of Physicians and Surgeons, and Director, New York State Psychiatric Institute, New York, USA

  2. 2

    Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA

Publication History

  1. Published Online: 3 JUL 2006
  2. Published Print: 31 MAR 2006

ISBN Information

Print ISBN: 9780470028216

Online ISBN: 9780470029435

SEARCH

Keywords:

  • dementia in Alzheimer's disease (AD);
  • pharmacokinetics;
  • drug selection;
  • conceptual treatment approach;
  • treatment initiation;
  • maintenance treatment;
  • treatment evaluation;
  • adverse effect of cholinesterase inhibitors;
  • drug interactions;
  • ChIs and memantine treatment in AD

Summary

This chapter contains sections titled:

  • Introduction

  • Pharmacology

  • Indications

  • Drug Selection

  • Treatment Initiation

  • Adverse Effects

  • Drug Interactions

  • Summary

  • Additional Reading